Exploratory Study of Pagoclone in Men With Premature Ejaculation.

Completed · Phase 2

Conditions studied: Premature Ejaculation

In brief

The purpose of this study is to evaluate pagoclone in the treatment of premature ejaculation.

Key facts

Study ID

NCT00370981

Run by

Endo USA Inc., a Keenova Therapeutics Company

People needed

100

Starts

2006-07-01

Expected to finish

2006-10-01

Last updated by the study team

2013-12-27

Who can join

Age: 18 and older, up to 55. Sex: male. Healthy volunteers: not accepted.

You may qualify if…

• A male regularly experiencing premature ejaculation
• 18 to 55 yrs old
• In a Stable relationship with one woman for at least 6 months

Where it is running

• Urology Centers of Alabama, PC — Homewood, Alabama, United States
• SD Uro-Research — San Diego, California, United States
• Urology Research Options — Aurora, Colorado, United States
• Urology Associates, PC — Denver, Colorado, United States
• Connecticut Clinical Research Center — Waterbury, Connecticut, United States
• South Florida Medical Research — Aventura, Florida, United States
• Northeast Indiana Research, LLC — Fort Wayne, Indiana, United States
• Davis Clinic, PC — Indianapolis, Indiana, United States
• Regional Urology, LLC — Shreveport, Louisiana, United States
• AccuMed Research Associates — Garden City, New York, United States
• Urological Surgeons of Long Island, PC — Garden City, New York, United States
• Center for Urologic Research of WNY — Williamsville, New York, United States
• Metrolina Urology Clinic — Charlotte, North Carolina, United States
• Wake Research Associates, LLC — Raleigh, North Carolina, United States
• Johnny B. Roy, MD Private Practice — Edmond, Oklahoma, United States
• Mobley Research Center — Houston, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.